My Watchlist for Thursday, February 09

( click to enlarge )
Wendys Co (NASDAQ:WEN) is still trading around the $14 level which has been a strong resistance over the past weeks. I plan to buy the stock if it can break Wednesday's high of $14.09. The trend is still up.

( click to enlarge )
Still watching Cellectar Biosciences Inc (NASDAQ:CLRB), will buy on a close above $1.85 (declining EMA100).

( click to enlarge )
Vical Incorporated (NASDAQ:VICL) has a chart set to breakout (EMA50). Today, the stock traded more than 662K shares, ten times higher than average and ran as high as 6% from Tuesday’s close. I strongly believe this bullish momentum to continue into tomorrow’s trading session. New bullish MACD cross has occurred on the daily chart. Potential swing long above 2.34 targeting the 2.8 area.

( click to enlarge )
I have ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) on my watchlist for Thursday. It might attempt to breakout above $1.65 level again and if it succeed we should expect a strong move to the upside.

( click to enlarge )
DragonWave, Inc.(USA) (NASDAQ:DRWI) There are some signs of a possible bounce at this point due to the extreme oversold conditions and some positive divergences on MACD, which often leads to short covering. A reversal may be on the way. Im long.

( click to enlarge )
BlackBerry Ltd (NASDAQ:BBRY) we start to see now some signals of rebound as the daily technical chart shows positive momentum is back. Nearest resistance for the stock is at $7.35. If this level is crossed and the stock is able to sustain above this level, then it might go to $8

( click to enlarge )
Nivalis Therapeutics Inc (NASDAQ:NVLS) surged in the final hour of trading closing at 2.41. The real fireworks should begin if the stock price can close above $2.53. The accumulation line is starting to curl upward which should eventually lead to price increases. Keep it on your watch list going forward.

If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.